ResearcherColumbia UniversityNo recent work listed
Myles A. Ingram
Matched on ORCID iD 0000-0001-9703-5805; OpenAlex author ID A5012469947. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2022: 2 papers
Papers 2
- Cost-effectiveness of neoadjuvant FOLFIRINOX versus gemcitabine plus nab-paclitaxel in borderline resectable/locally advanced pancreatic cancer patients. Co-author DOI 10.1002/cnr2.1565↗
- Deep learning on time series laboratory test results from electronic health records for early detection of pancreatic cancer. Co-author DOI 10.1016/j.jbi.2022.104095↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jiheum Park · 2 shared papers, 2022 · strength 0.31
- Paper Deep learning on time series laboratory test results from electronic health records for early detection of pancreatic c… DOI 10.1016/j.jbi.2022.104095↗
- Paper Cost-effectiveness of neoadjuvant FOLFIRINOX versus gemcitabine plus nab-paclitaxel in borderline resectable/locally ad… DOI 10.1002/cnr2.1565↗
- Chin Hur · 2 shared papers, 2022 · strength 0.31
- Paper Deep learning on time series laboratory test results from electronic health records for early detection of pancreatic c… DOI 10.1016/j.jbi.2022.104095↗
- Paper Cost-effectiveness of neoadjuvant FOLFIRINOX versus gemcitabine plus nab-paclitaxel in borderline resectable/locally ad… DOI 10.1002/cnr2.1565↗
- Nicholas P. Tatonetti · 1 shared paper, 2022 · strength 0.16
- Chung Yin Kong · 1 shared paper, 2022 · strength 0.15
- Susan Elaine Bates · 1 shared paper, 2022 · strength 0.15
- Gulam Abbas Manji · 1 shared paper, 2022 · strength 0.15
- Fay Kastrinos · 1 shared paper, 2022 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.